BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 18578558)

  • 1. Calcineurin inhibitor sparing in paediatric solid organ transplantation : managing the efficacy/toxicity conundrum.
    Tredger JM; Brown NW; Dhawan A
    Drugs; 2008; 68(10):1385-414. PubMed ID: 18578558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result.
    Srinivas TR; Meier-Kriesche HU
    Clin J Am Soc Nephrol; 2008 Mar; 3 Suppl 2(Suppl 2):S101-16. PubMed ID: 18308998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of two immunosuppressants: tacrolimus and cyclosporine.
    Lee H; Myoung H; Kim SM
    J Korean Assoc Oral Maxillofac Surg; 2023 Dec; 49(6):311-323. PubMed ID: 38155084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive Drugs in Liver Transplant: An Insight.
    Panackel C; Mathew JF; Fawas N M; Jacob M
    J Clin Exp Hepatol; 2022; 12(6):1557-1571. PubMed ID: 36340316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus Long-Term Tolerability and Impact on Kidney Function in Lung Transplantation: A Single-Center Experience.
    Feist AA; Mariski M; Awdishu L; Bremer M; Yung G; Jung C; Golts E; Afshar K
    Transplant Proc; 2023 Dec; 55(10):2470-2477. PubMed ID: 37891020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the reduction of calcineurin inhibitors on renal function in heart transplant patients: a systematic review and meta-analysis.
    Cornu C; Dufays C; Gaillard S; Gueyffier F; Redonnet M; Sebbag L; Roussoulières A; Gleissner CA; Groetzner J; Lehmkuhl HB; Potena L; Gullestad L; Cantarovich M; Boissonnat P
    Br J Clin Pharmacol; 2014 Jul; 78(1):24-32. PubMed ID: 24251918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Prevalence of Parkinson's Disease in Patients Prescribed Calcineurin Inhibitors.
    Silva JD; Jupiter DC; Taglialatela G
    J Parkinsons Dis; 2024; 14(3):533-543. PubMed ID: 38427501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular Immunobiology and Molecular Mechanisms in Alloimmunity-Pathways of Immunosuppression.
    Schrezenmeier E; Dörner T; Halleck F; Budde K
    Transplantation; 2024 Jan; 108(1):148-160. PubMed ID: 37309030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reviewing 15 years of experience with sirolimus.
    Tedesco Silva H; Rosso Felipe C; Medina Pestana JO
    Transplant Res; 2015; 4(Suppl 1):6. PubMed ID: 27293553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Prevalence of Dementia in Patients Prescribed Tacrolimus, Sirolimus, or Cyclosporine.
    Silva JD; Taglialatela G; Jupiter DC
    J Alzheimers Dis; 2023; 95(2):585-597. PubMed ID: 37574739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive update of the metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation.
    Vidigal AC; de Lucena DD; Beyerstedt S; Rangel ÉB
    Expert Opin Drug Metab Toxicol; 2023; 19(7):405-427. PubMed ID: 37542452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic consequences of modern immunosuppressive agents in solid organ transplantation.
    Bamgbola O
    Ther Adv Endocrinol Metab; 2016 Jun; 7(3):110-27. PubMed ID: 27293540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin inhibitor (CNI)-associated skin cancers: New insights on exploring mechanisms by which CNIs downregulate DNA repair machinery.
    Ume AC; Pugh JM; Kemp MG; Williams CR
    Photodermatol Photoimmunol Photomed; 2020 Nov; 36(6):433-440. PubMed ID: 32786098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-2 receptor engineering enhances regulatory T cell function suppressed by calcineurin inhibitor.
    Hirai T; Lin PY; Ramos TL; Simonetta F; Su LL; Picton LK; Baker J; Lohmeyer JK; Garcia KC; Negrin RS
    Am J Transplant; 2022 Dec; 22(12):3061-3068. PubMed ID: 36031344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressant Medications in Pregnancy.
    Saad AF; Pacheco LD; Saade GR
    Obstet Gynecol; 2024 Apr; 143(4):e94-e106. PubMed ID: 38227938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing dyslipidemia in solid organ transplant patients.
    Mehta A
    Indian Heart J; 2024 Mar; 76 Suppl 1(Suppl 1):S93-S95. PubMed ID: 38199560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How calcineurin inhibitors affect cognition.
    Thiankhaw K; Chattipakorn N; Chattipakorn SC
    Acta Physiol (Oxf); 2024 Jul; 240(7):e14161. PubMed ID: 38747643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of everolimus in liver transplantation.
    Yee ML; Tan HH
    World J Hepatol; 2017 Aug; 9(23):990-1000. PubMed ID: 28878864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KidneyCare Guided Immuno-Optimization in Renal Allografts: The KIRA Protocol.
    Gray JN; Wolf-Doty T; Sulejmani N; Gaber O; Axelrod D; Abdalla B; Danovitch G
    Methods Protoc; 2020 Sep; 3(4):. PubMed ID: 33007896
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.